SHANNON FISHER: Open Payments
NPI 1417654500 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,279 in 93 payments from 22 companies in 2025. Trend: 2023 $1,695 · 2024 $2,190 · 2025 $2,279
Food & beverage: $2,167Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $553 |
| Neurocrine BioSciences, Inc. | 19 | $251 |
| ABBVIE INC. | 6 | $229 |
| Alkermes, Inc. | 9 | $223 |
| AstraZeneca Pharmaceuticals LP | 3 | $159 |
| Indivior Inc. | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| Janssen Pharmaceuticals, Inc | 3 | $87 |
| Insulet Corporation | 4 | $60 |
Products named: UZEDY, INGREZZA, MAVYRET, ARISTADA, SUBLOCADE, BREZTRI, REXULTI, CAPLYTA.
Industry payments across CO — which companies pay providers there.
